Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M4,549Revenue $M2,506Net Margin (%)17.3Altman Z-Score0.9
Enterprise Value $M8,279EPS $3.9Operating Margin %8.0Piotroski F-Score4
P/E(ttm)13.6Beneish M-Score-2.4Pre-tax Margin (%)-1.2Higher ROA y-yY
Price/Book3.110-y EBITDA Growth Rate %--Quick Ratio1.4Cash flow > EarningsN
Price/Sales1.85-y EBITDA Growth Rate %--Current Ratio1.7Lower Leverage y-yY
Price/Free Cash Flow73.2y-y EBITDA Growth Rate %-11.7ROA % (ttm)5.9Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)18.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M86.3ROIC % (ttm)1.9Gross Margin Increase y-yN

Gurus Latest Trades with ALR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ALRPrivate Capital 2015-12-31 Reduce-0.06%$38.21 - $50.57
($42.74)
$ 52.7423%Reduce -1.20%930,548
ALRJohn Keeley 2015-12-31 Reduce-0.01%$38.21 - $50.57
($42.74)
$ 52.7423%Reduce -1.01%964,189
ALRMario Gabelli 2015-12-31 Add$38.21 - $50.57
($42.74)
$ 52.7423%Add 0.86%235,430
ALRJohn Keeley 2015-09-30 Reduce-0.09%$45.76 - $55.39
($51.83)
$ 52.742%Reduce -6.81%974,047
ALRPrivate Capital 2015-09-30 Add0.08%$45.76 - $55.39
($51.83)
$ 52.742%Add 1.59%941,823
ALRMario Gabelli 2015-09-30 Add$45.76 - $55.39
($51.83)
$ 52.742%Add 6.88%233,430
ALRJohn Keeley 2015-06-30 Reduce-0.2%$47.48 - $52.75
($50.3)
$ 52.745%Reduce -15.76%1,045,227
ALRPrivate Capital 2015-06-30 Add0.09%$47.48 - $52.75
($50.3)
$ 52.745%Add 1.74%927,113
ALRMario Gabelli 2015-06-30 Add$47.48 - $52.75
($50.3)
$ 52.745%Add 4.92%218,400
ALRJoel Greenblatt 2015-03-31 Sold Out -0.12%$36.72 - $49.06
($43.88)
$ 52.7420%Sold Out0
ALRJohn Keeley 2015-03-31 Reduce-0.08%$36.72 - $49.06
($43.88)
$ 52.7420%Reduce -8.03%1,240,717
ALRPrivate Capital 2015-03-31 Add0.05%$36.72 - $49.06
($43.88)
$ 52.7420%Add 1.00%911,238
ALRMario Gabelli 2015-03-31 Add$36.72 - $49.06
($43.88)
$ 52.7420%Add 2.49%208,150
ALRJoel Greenblatt 2014-12-31 Buy 0.12%$36.31 - $40.2
($38.6)
$ 52.7437%New holding382,075
ALRMario Gabelli 2014-12-31 Reduce-0.01%$36.31 - $40.2
($38.57)
$ 52.7437%Reduce -23.00%203,100
ALRJoel Greenblatt 2014-09-30 Sold Out -0.01%$34.26 - $41.14
($37.35)
$ 52.7441%Sold Out0
ALRJohn Keeley 2014-06-30 Buy 0.9%$32.86 - $37.68
($35.57)
$ 52.7448%New holding1,335,700
ALRMario Gabelli 2014-06-30 Add0.03%$32.86 - $37.68
($35.57)
$ 52.7448%Add 206.84%242,845
ALRJoel Greenblatt 2014-06-30 Buy 0.01%$32.86 - $37.68
($35.57)
$ 52.7448%New holding11,057
ALRMario Gabelli 2014-03-31 Add0.01%$33.99 - $39.34
($36.55)
$ 52.7444%Add 646.65%79,145
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ALR is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ALR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Guerdan MelissaSVP, Global Quality & Reg. 2016-02-01Sell2,500$54-2.33view
Hargadon Robert BernardSVP, Global Human Resources 2015-11-13Buy1,000$38.9935.27view
Hinrichs James F.Executive VP, CFO 2015-11-12Buy10,000$39.9731.95view
Guerdan MelissaSVP, Global Quality & Reg. 2015-09-03Sell5,135$521.42view
Gladwell MarkSenior VP, Global Operations 2015-09-03Sell2,651$52.270.9view
Guerdan MelissaSVP, Global Quality & Reg. 2015-09-01Sell5,000$50.484.48view
Gladwell MarkSenior VP, Global Operations 2015-08-31Sell27,513$52.230.98view
Malkani SanjayGlobal Pres., Toxicology 2015-08-14Sell31,460$54.6-3.41view
Hinrichs James F.Executive VP, CFO 2015-08-07Buy20,000$49.336.91view
Malkani SanjayGlobal Pres., Toxicology 2015-06-08Sell24,331$50.873.68view

Press Releases about ALR :

Quarterly/Annual Reports about ALR:

News about ALR:

Articles On GuruFocus.com
The Transformation in Alere May 22 2015 
Diamond Hill Capital Comments on Alere Inc Mar 17 2015 
Corsair Capital's Analysis of Alere Mar 06 2015 
DENTSPLY´s Growth Opportunities Dec 16 2014 
Hologic Produces the First FDA-Approved 3D Mammography Platform Nov 26 2014 
Mario Gabelli Comments on Alere Inc Nov 21 2014 
Mario Gabelli’s Asset Fund Q3 2014 Commentary Nov 21 2014 
Cohen Has Busy Third Quarter Nov 19 2014 
Diamond Hill Capital Comments on Alere Inc Oct 17 2014 
Diamond Hill Select Fund Third Quarter 2014 Commentary Oct 17 2014 

More From Other Websites
INVESTOR ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Alere, Inc. and... Feb 12 2016
ALERE SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Alere Inc. (ALR) Over... Feb 10 2016
The Alere-Abbott Labs Merger: Understanding the Alere Side Feb 09 2016
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Alere Inc. of an Investigation... Feb 09 2016
SHAREHOLDER ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Alere, Inc. and... Feb 08 2016
INVESTOR ALERT: The Law Offices of Vincent Wong Launches an Investigation of the Board of Directors... Feb 08 2016
Law Offices of Marc S. Henzel Announces Investigation of Companies for Violations of the Federal... Feb 08 2016
Finding Value in These Names -- Agilent Technologies, Exact Sciences, Thermo Fisher Scientific, and... Feb 08 2016
Top 4 BioPharma Movers of the Week Feb 06 2016
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Alere Inc. of an Investigation in... Feb 05 2016
ALERE SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Alere Inc. (ALR) Over... Feb 04 2016
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Launches an Investigation of the Board of... Feb 04 2016
​Alere executives stand to reap $24M in payouts with Abbott buyout Feb 04 2016
Rationale for the Alere–Abbott Laboratories Merger Feb 04 2016
Abbott Labs Beefs Up Its Diagnostics Portfolio with Alere Feb 04 2016
Harwood Feffer LLP Announces Investigation of Alere Inc. Feb 03 2016
EKF Diagnostics kitchen-sinking will drive break-even 'by April' Feb 03 2016
Abbott Labs to Boost Diagnostics Business with Alere Buyout Feb 02 2016
CEMI: Zika Could Be Seamless Fit to CEMI's Fever Portfolio Feb 02 2016
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Alere Inc. of an Investigation... Feb 02 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK